期刊文献+

子宫内膜、卵巢原发双癌组织中端粒酶及ER、c-myc的表达 被引量:1

Expression of telomerase,estrogen receptor and c-myc in synchronous primary endometrial and ovarian carcinomas
下载PDF
导出
摘要 目的探讨宫腔子宫内膜样腺癌和卵巢子宫内膜样腺癌(原发双癌)组织中端粒酶及雌激素受体(ER)、c-myc蛋白的表达。方法收集16例子宫内膜和卵巢原发双癌患者的癌组织切除标本,临床病理分期均为Ⅰ期。采用免疫组织化学PV-6000二步法分别检测免疫表型端粒酶、ER及c-myc在同一患者子宫内膜癌组织和卵巢癌组织中的表达。结果子宫内膜和卵巢两部位癌组织端粒酶蛋白表达相同11例(68.75%),表达不同5例(31.25%);ER蛋白表达相同10例(62.5%),表达不同6例(37.5%);c-myc蛋白表达相同10例(62.5%),表达不同6例(37.5%);子宫内膜癌和卵巢癌组织中端粒酶、ER及c-myc表达均差异无统计学意义(P均>0.05)。子宫内膜和卵巢两部位原发双癌中均有ER、c-myc及端粒酶蛋白表达7例(43.75%)。结论端粒酶、ER及c-myc在子宫内膜和卵巢两部位原发双癌中的表达可能相同,两部位癌组织可能存在同源性。 Objective To investigate the expression of telomerase,estrogen receptor (ER) and c-myc protein in synchronous primary endometriod adenocarcinomas of the uterus and ovarian.Methods A total of 16 synchronous primary endometrial and ovarian carcinomas surgical specimens were collected.All patients' clinical-pathological stage was Ⅰ stage,immunohistochemical PV-6000 two-step was used to detect the immunophenotype of telomerase (hTERT),ER and c-myc expression in uterine and ovarian carcinomas at one patient.Results Eleven cases (68.75%) had the same immunophenotype of telomerase in the tissues of uterine and ovarian carcinomas,and 5 patients (31.25%) had different telomerase expression; ten cases (62.5%) had the same immunophenotype of ER common to uterine and ovarian carcinomas,and 6 cases (37.5%) had different ER expression; ten cases (62.5%) had the same immunophenotype of c-myc,and 6 cases (37.5%) had different c-myc expression.There were no statistically significant differences in the expression of telomerase,ER and c-myc protein in synchronous primary endometriod adenocarcinomas of the uterus and ovarian (all P > 0.05).There were 7 cases (43.75%) of positive expression of ER,c-myc and telomere in both uterine and ovarian endometriod adenocarcinomas.Conclusion The expression of telomerase,ER and c-myc may be similar in the synchronous primary carcinomas of uterine and ovarian,and there may be homology between two sites cancers.
出处 《山东医药》 CAS 2014年第1期20-23,共4页 Shandong Medical Journal
关键词 卵巢肿瘤 子宫内膜肿瘤 原发双癌 免疫组织化学 ovarian neoplasms endometrial neoplasms synchronous primary carcinoma immunohistochemistry
  • 相关文献

参考文献18

  • 1Crum CP, Drapkin R, Miron A, et al. The distal fallopian tube:a new model for pelvic serous carcinogenesis [ J ]. CmT Opin Obstet Gynecol, 2007,19( 1 ) :3-9.
  • 2Levanon K, Crum C, Drapkin R. New insights into the pathogene- sis of serous ovarian cancer and its clinical impact[ J]. J Clin On- col, 2008,26(32) :5284-5293.
  • 3Wiegand KC, Shah SP, M-Agha OM, et M. ARID1A mutations in endoosismetri-associated ovarian carcinomas[ J ]. N Engl J Med, 2010,363(16) :1552-1543.
  • 4Young RH, Scully RE. Metastetic tumor of the ovary [ M ]//Kur- man RJ. Blumstein's gynecologic pathology of the tmal genital tract. 5th ed. New York : Sprixger, 2002 : 1063-1101.
  • 5Maraei AA, Hatta AZ, Shiran MS, et al. Human telomerase re- verse transcfiptase expression in ovarian tumors [ J ]. Indian J Pathol Microbiol, 2012,55 (2) : 187-191.
  • 6Vandenput I, Trovik J , Leunen K, et al. Evolution in endometrial cancer evidence from an irnmunohistochemical study[ J]. lnt J Gy- necol Cancer, 2011,21 ( 2 ) :316-322.
  • 7Liu J, Xiao J, Tao Z, et al. Detection of c-myc gene expression in nasopharyngeal carcinoma by nonradioactive in situ hybridization anti immune is to chemistl7 [ J ]. Chin Med J ( Engl ) , 1997,110 (3) :229-232.
  • 8Chen GG, Zeng Q, Tse GM. Estrogen and it receptors in cancer [J]. MedRes Rev, 2008,28(6) :954-974.
  • 9Tamaya D, Motoyama T, Ohono Y, eL al. Steroid reeeptor levels and histology of edometriosis nd adelao,qyosis [J]. FertileSterile.1979,31 (4) :396-400.
  • 10Janne O, Kauppila A, Kokko E, et al . Estrogen and progesterone receptors in endometrisis lesions:comparison with endometrial Tis- sue[ J]. Am J Obstet Gynecol, 1981,141 (5) :562-566.

同被引文献12

  • 1许霞辉,贺兼斌,张平.人参皂苷Rg3联合苏拉明对小鼠肺癌生长影响及其机制的探讨[J].中华肿瘤防治杂志,2013,20(2):97-101. 被引量:12
  • 2Marchetti D,Reiland J,Erwin B,et al.Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues. International Journal of Cancer . 2003
  • 3Monk B J,Chapman J A,Johnson G A,Brightman B K,Wilczynski S P,Schell M J,Fan H.Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancer. American journal of obstetrics and gynecology . 1994
  • 4Gabriella Gamberi,M Serena Benassi,Tom Bohling,Paola Ragazzini,Lara Molendini,M Rosa Sollazzo,Franca Pompetti,Mara Merli,Giovanna Magagnoli,Alba Balladelli,Piero Picci.C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression. Oncology . 1998
  • 5Doviner Victoria,Maly Bella,Kaplan Victoria,Gingis-Velitski Svetlana,Ilan Neta,Vlodavsky Israel,Sherman Yoav.Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc . 2006
  • 6Frederic Amant,Philippe Moerman,Patrick Neven,Dirk Timmerman,Erik Van Limbergen,Ignace Vergote.??Endometrial cancer(J)The Lancet . 2005 (9484)
  • 7Li H,Li H,Qu H,et al.Suramin inhibits cell proliferation in ovarian and cervical cancer by down regulating heparanase expression. Cancer Cell International . 2015
  • 8Sarah Bhargava,Birgit Hotz,O. Joe Hines,Howard A. Reber,Heinz J. Buhr,Hubert G. Hotz.??Suramin Inhibits Not Only Tumor Growth and Metastasis but Also Angiogenesis in Experimental Pancreatic Cancer(J)Journal of Gastrointestinal Surgery . 2007 (2)
  • 9李华萍,朱前勇,崔金全,孙国俭.苏拉明对体外培养的人卵巢癌细胞HO-8910PM增殖及乙酰肝素酶表达的影响[J].中国妇产科临床杂志,2010,11(2):131-135. 被引量:5
  • 10莫秋荣,梁科庆,农勤高,苏赓,温伟.子宫内膜癌中c-Myc和cyclin E的表达及临床意义[J].临床肿瘤学杂志,2013,18(11):986-989. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部